A clinical registry to monitor outcomes of shoulder and knee pathology

Not Applicable

Recruiting

• Conditions: Shoulder arthritis; Shoulder dislocation/recurrent instability; Shoulder rotator cuff pathology; Knee arthritis; Knee ACL rupture; Hip Osteoarthritis; Musculoskeletal - Osteoarthritis; Musculoskeletal - Other muscular and skeletal disorders; Surgery - Other surgery

• Registration Number: ACTRN12617001161314
• Lead Sponsor: QEII Jubilee Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-08-08
• Last Update Posted: 28 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2500

Inclusion Criteria

Diagnosed with orthopaedic shoulder, hip or knee pathology in one of the identified cohorts.
Undergoing treatment by one of the participating orthopaedic consultant surgeons as a public patient at QEII Jubilee Hospital or Mater Adults Hospital.
Consenting to being part of the research registry

Exclusion Criteria

Patient-reported outcomes: Clinically diagnosed mental/neurological illness (indicated on GP referral, or identified through secondary referral to psychiatric/neurological specialist) that precludes retrieval of patient feedback via interview, paper or electronic questionnaire (e.g., schizophrenia, dementia, Alzheimer's Disease, personality disorder).
Revocation of consent for research use of personal data.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pdateThe incidence of patients that are deemed a failure to cure following definitive treatment Insufficient improvement in patient reported outcome measures (function or pain) - Based on secondary outcomes identified and matched to the specific cohort. eg. A CS score with a MCID of 10.4 for rotator cuff repair; adverse findings on post-treatment medical imaging - determined by the reviewing surgeon based on imaging secondary outcomes identified; positive signs of instability, weakness or other primary pathology during clinical follow-up - as determined by the reviewing surgeon based on strength and instability tests identified as secondary outcomes; failure to improve shoulder, hip or knee range of motion - as determined by the reviewing surgeon based on range of motion tests identified as secondary outcomes.[2 years after clinical diagnosis within the specialist orthopaedic practice or following definitive treatment (non-operative OR surgical). ]